Beacon Webinars
Welcome to our comprehensive webinar resource page, your gateway to invaluable insights and expertise across our Beacon modalities. Here, you’ll find a collection of on-demand webinars, each thoughtfully crafted and delivered by our expert team. These webinars provide an abundant amount of commercial and research insights that serve to support your investment and drug development decisions.
Home > Webinar Resources
Upcoming Webinars
Watch Our Previous Sessions On Demand
Webinar – The Future of Cell Therapies: An In-Depth Analysis of the 2023 Commercial and Research Landscape
Webinar – Realizing the Full Potential within the RNA and Gene Therapy Landscapes: 2023 So Far
Webinar – Gene Therapy: Optimizing the Safety of Viral Vectors
Webinar – The ADC Boom: Navigating the Expansive Landscape of Antibody-Drug Conjugates
Webinar – Bispecific Antibodies and Immune Checkpoint Modulators: A H1 Landscape Analysis
Webinar – Examining the Cytokine-Based Drug Development Landscape: Interleukins and Beyond
Webinar – Unlocking the Value of Microbiome-Targeting Therapeutics in Combating Infectious Diseases
Webinar – T Cell Therapies: The Road Ahead for Addressing Autoimmune Indications
Webinar – The TPD Disease Landscape: Oncology vs. Non-Oncology
Webinar – The DDR Landscape: The Past, Present & Future
Additional Content
Cytokine TOI Digest Axatilimab Approval
DDRi and ADC Combination Therapies Infographic
Webinar – Unlocking the Future of RNA Therapeutics: Delivery System Evolution, Preclinical Insights, and Market Impact
H1 2024 Oncolytic Viruses Landscape Review
H1 2024 Cytokine Landscape Review
H1 2024 Cancer Vaccine Landscape Review
H1 2024 Microbiome Landscape Review
The 2024 H1 TPD Landscape Review
H1 2024 Immune Tolerance Landscape Review
The 2024 DDR H1 Landscape Review
H1 2024 Bispecific Landscape Review
H1 2024 RNA Landscape Review
About Beacon
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.